Increased quinidine plasma concentrations during administration of verapamil: A new quinidine-verapamil interaction

Richard G. Trohman, Daneil M. Estes, Agustin Castellanos, Andres R. Palomo, Robert J. Myerburg, Kenneth M. Kessler

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

A number of drug interactions that involve quinidine have been reported.1 These include both pharmacokinetic interactions in which plasma concentrations of other drugs, most notably digoxin, are influenced by quinidine, and pharmacologic interactions. The latter is exemplified by a recent report of marked hypotension when intravenous verapamil was given to patients receiving oral quinidine preparations.2 This hypotension was presumably due to α-adrenergic blockade and the peripheral vasodilatation was a result of both quinidine and verapamil. We report a patient with cyanotic congenital heart disease and atrial flutter with 1:1 atrioventricular conduction who had a previously unreported quinidine-verapamil pharmacokinetic interaction.

Original languageEnglish (US)
Pages (from-to)706-707
Number of pages2
JournalThe American Journal of Cardiology
Volume57
Issue number8
DOIs
StatePublished - May 3 1986

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Increased quinidine plasma concentrations during administration of verapamil: A new quinidine-verapamil interaction'. Together they form a unique fingerprint.

Cite this